Oncology and Hematology
65-80 of 592
- MinuteCE®
Breaking Down the Benchmarks: Pivotal Data on First-Line CDK4/6 Inhibitors
1.00 program credit
Giuseppe Curigliano, MD, PhD
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Komal Jhaveri, MD, FACP
- MinuteCE®
Doublet or Triplet? A Case-Based Debate in First-Line Choices for HR+/HER2- mBC
1.00 program creditGiuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Komal Jhaveri, MD, FACP
Giuseppe Curigliano, MD, PhD
Cynthia Villarreal-Garza, MD, DSc
Hiraji Iwata, MD, PhD
Alexandria May, PharmD, BCPS
Angela Waanders, MD, MPH, MS
Ashley S. Margol, MD, MS
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Charles Turck, PharmD, BCPS, BCCCP
Timothy Kubal, MD
Vinod Pullarkat, MD
Charles Turck, PharmD, BCPS, BCCCP
Jamie Koprivnikar, MD
Abdulraheem Yacoub, MD
Jennifer Caudle, DO, FACOFP
Catherine Broome, MD
Brian P. McDonough, MD, FAAFP
